Informação sobre produto
- Chlorcyclizine Hydrochloride
- Piperazine
- 1-[(4-chlorophenyl)phenylmethyl]-4-methyl-
- hydrochloride (1:1)
- Piperazine
- 1-[(4-chlorophenyl)phenylmethyl]-4-methyl-
- monohydrochloride (9CI)
- Chlorcyclizine chloride
- Chlorcyclizine hydrochloride
- Chlorcyclizine monohydrochloride
- Ver mais sinónimos
- Di-Paralene
- Histantin
- NSC 169496
- Perazil
- Piperazine
- 1-(p-chloro-alpha-phenylbenzyl)-4-methyl-
- monohydrochloride (8CI)
- 1-(P-Chloro-Alpha-Phenylbenzyl)-4-Methyl-Piperazinhydrochloride
- 1-(P-Chloro-Alpha-Phenylbenzyl)-4-Methylpiperazinehydrochloride
- 1-(P-Chlorobenzhydryl)-4-Methylpiperazinehydrochloride
- 1-(p-Chloro-alpha-phenylbenzyl)-4-methylpiperazine hydrochloride
- 1-(p-Chloro-alpha-phenylbenzyl)-4-methylpiperazine monohydrochloride
- 1-[(4-Chlorophenyl)(Phenyl)Methyl]-4-Methylpiperazine
- 1-[(4-Chlorophenyl)(Phenyl)Methyl]-4-Methylpiperazine Hydrochloride (1:1)
- 1-[(4-Chlorophenyl)Phenyl-Methyl]-4-Methylpiperazine Hydrochloride
- Chlorcyclizine HCL
- Chlorcycliziniumchloride
- Eramide
- Mantadil
- Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, hydrochloride
- Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, monohydrochloride
- Piperazine, 1-(p-chloro-alpha-phenylbenzyl)-4-methyl-, hydrochloride
- Piperazine, 1-(p-chloro-α-phenylbenzyl)-4-methyl-, monohydrochloride
- Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-methyl-, hydrochloride (1:1)
- Unii-Npb7A7874U
Applications An antihistaminic drug. A drug analog of Cyclizine (C987805).
References Leurs, R., et al.: Pharmacol. Ther., 66, 413 (1995), Hu, Q., et al.: J. Biol. Chem., 274, 33995 (1999), Church, M., et al.: Clin. Exp. Allergy, 31, 1341 (2001),
Propriedades químicas
Consulta técnica sobre: TR-C326500 Chlor Cyclizine Hydrochloride
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.